# RCT of SPG Blocks for Post-dural Headache

> **NCT03560349** · PHASE2 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Post-Dural Puncture Headache

## Interventions

- **DRUG:** Lidocaine HCl Gel 2%
- **DRUG:** placebo gel

## Key facts

- **NCT ID:** NCT03560349
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Both Study PI's left the institution
- **Last updated:** 2022-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560349, "RCT of SPG Blocks for Post-dural Headache". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT03560349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*